CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Udg Healthcare Plc Company Snapshot
UDG Healthcare PLC, formerly United Drug PLC, provides advisory, commercial, clinical, communications and packaging services to the healthcare industry with operations in approximately 24 countries and delivering services in over 50 countries. The Company operates across three divisions: Ashfield, which provides commercialization services for the pharmaceutical and healthcare industry and operates across two areas of activity: advisory & communications services and commercial & clinical services and provides healthcare communications, patient support, audit, advisory, medical information and event management services; Sharp, which provides contract commercial packaging and clinical trial packaging services for the pharmaceutical and biotechnology industries and operates facilities in the United States and Europe; and Aquilant, which provides outsourced sales, marketing, distribution and engineering services to the medical and scientific sectors in the UK, Ireland and the Netherlands.

Sales Analysis. Udg Healthcare Plc reported sales of 1.10 billion Euro (US$1.35 billion) for the fiscal year ending September of 2017. This represents an increase of 16.5% versus 2016, when the company's sales were 943.08 million Euro. Sales of Ashfield saw an increase of 26.6% in 2017, from 584.45 million Euro to 739.63 million Euro.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Udg Healthcare Plc
  Stock Performance Chart for Udg Healthcare Plc
 
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 8.92
(Figures in Euro)
1 Week -4.2%   13 Weeks -11.0%  
4 Weeks -12.8%   52 Weeks 18.1%  
 
Udg Healthcare Plc Key Data:
  Ticker: UDG Country: Ireland
  Exchanges: LON Major Industry: Health Care Equipment & Services
    Sub Industry: Drugs, Proprietaries, & Sundries
  2017 Sales 1,098,316,192
(Year Ending Jan 2018).
Employees: 7,921
  Currency: Euro Market Cap: 2,215,494,229
  Fiscal Yr Ends: September Shares Outstanding: 248,326,744
  Share Type: Ordinary Closely Held Shares: 2,743,175
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.